Risk-Adapted Melphalan and Stem Cell Transplantation after Suboptimal Responses to Bortezomib-Based Initial Therapy in Patients with Systemic Light-Chain Amyloidosis (AL)

被引：0
|
作者：
Wong, Sandy W. [1 ]
Larivee, Denise [2 ]
Warner, Melissa [1 ]
Sprague, Kellie [1 ]
Fogaren, Terry [1 ]
Comenzo, Raymond L. [1 ]
机构：
[1] Tufts Med Ctr, John C Davis Myeloma & Amyloid Program, Div Hematol Oncol, Boston, MA USA
[2] Tufts Med Ctr, Div Hematol Oncol, Boston, MA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5831.5831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5831
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy
    Wong, S. W.
    Larivee, D.
    Warner, M.
    Sprague, K. A.
    Fogaren, T.
    Comenzo, R. L.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 (06) : 936 - 937
  • [2] Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy
    S W Wong
    D Larivee
    M Warner
    K A Sprague
    T Fogaren
    R L Comenzo
    [J]. Bone Marrow Transplantation, 2017, 52 : 936 - 937
  • [3] Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)
    Landau, H. J.
    Hoffman, J.
    Hassoun, H.
    Elizabeth, H.
    Riedel, E.
    Nimer, S. D.
    Cohen, A.
    Comenzo, R. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
    Landau, H.
    Hassoun, H.
    Rosenzweig, M. A.
    Maurer, M.
    Liu, J.
    Flombaum, C.
    Bello, C.
    Hoover, E.
    Riedel, E.
    Giralt, S.
    Comenzo, R. L.
    [J]. LEUKEMIA, 2013, 27 (04) : 823 - 828
  • [5] Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
    H Landau
    H Hassoun
    M A Rosenzweig
    M Maurer
    J Liu
    C Flombaum
    C Bello
    E Hoover
    E Riedel
    S Giralt
    R L Comenzo
    [J]. Leukemia, 2013, 27 : 823 - 828
  • [6] Adjuvant Bortezomib and Dexamethasone Following Risk-Adapted Melphalan and Stem Cell Transplant in Systemic Light-Chain Amyloidosis (AL): A Phase II Study
    Landau, Heather
    Hassoun, Hani
    Cohen, Adam D.
    Lesokhin, Alexander
    Bello, Christina
    Hoover, Elizabeth
    Riedel, Elyn R.
    Ciminiello, Jennifer
    McCullagh, Emily
    Nimer, Stephen D.
    Comenzo, Raymond
    [J]. BLOOD, 2009, 114 (22) : 222 - 223
  • [7] Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis
    Landau, H.
    Hassoun, H.
    Bello, C.
    Hoover, E.
    Jia, X.
    Riedel, E. R.
    Nimer, S. D.
    Comenzo, R. L.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 80 - 80
  • [8] Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis
    Landau, H.
    Hassoun, H.
    Bello, C.
    Hoover, E.
    Riedel, E. R.
    Nimer, S. D.
    Comenzo, R. L.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 : 135 - 136
  • [9] Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
    Landau, Heather
    Hassoun, Hani
    Bello, Christina
    Chou, Joanne
    Devlin, Sean
    Giralt, Sergio A.
    Comenzo, Raymond
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S131 - S131
  • [10] Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience.
    Landau, Heather
    Fein, Daniel E.
    Hassoun, Hani
    Bello, Christina
    Chou, Joanne F.
    Devlin, Sean
    Giralt, Sergio
    Comenzo, Raymond L.
    [J]. BLOOD, 2012, 120 (21)
12345